Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)
OTCMKTS
· Delayed Price · Currency is USD
9.36
0.00 (0.00%)
Jun 6, 2025, 4:00 PM EDT
SBLOF Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 6, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Market Capitalization | 390 | 398 | 418 | 861 | 581 | 263 | Upgrade
|
| Market Cap Growth | -4.78% | -4.78% | -51.49% | 48.12% | 120.98% | 28.80% | Upgrade
|
| Enterprise Value | 547 | 559 | 509 | 921 | 611 | 333 | Upgrade
|
| Last Close Price | 9.36 | 9.51 | 16.97 | - | - | - | Upgrade
|
| PE Ratio | 11.86 | 12.10 | 11.43 | 18.89 | 9.91 | 7.95 | Upgrade
|
| PS Ratio | 1.80 | 1.84 | 2.39 | 4.56 | 3.98 | 1.93 | Upgrade
|
| PB Ratio | 1.46 | 1.49 | 1.85 | 4.34 | 3.58 | 1.84 | Upgrade
|
| P/TBV Ratio | 1.54 | 1.57 | 1.98 | 4.67 | 3.65 | 1.88 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 16.01 | 7.91 | Upgrade
|
| P/OCF Ratio | 8.06 | 8.22 | 30.01 | 28.59 | 11.86 | 6.13 | Upgrade
|
| EV/Sales Ratio | 2.42 | 2.58 | 2.91 | 4.88 | 4.18 | 2.44 | Upgrade
|
| EV/EBITDA Ratio | 8.63 | 14.96 | 12.76 | 17.89 | 13.81 | 9.90 | Upgrade
|
| EV/EBIT Ratio | 12.09 | 28.04 | 18.49 | 23.35 | 17.68 | 14.55 | Upgrade
|
| EV/FCF Ratio | -22.70 | - | - | - | 16.82 | 10.00 | Upgrade
|
| Debt / Equity Ratio | 0.86 | 0.86 | 0.77 | 0.71 | 0.46 | 0.80 | Upgrade
|
| Debt / EBITDA Ratio | 6.16 | 6.16 | 4.34 | 2.74 | 1.70 | 3.41 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 2.07 | 3.45 | Upgrade
|
| Asset Turnover | 0.38 | 0.38 | 0.40 | 0.52 | 0.47 | 0.40 | Upgrade
|
| Inventory Turnover | 1.43 | 1.43 | 1.24 | 2.06 | 1.91 | 1.87 | Upgrade
|
| Quick Ratio | 0.63 | 0.63 | 0.69 | 0.73 | 0.79 | 0.86 | Upgrade
|
| Current Ratio | 1.13 | 1.13 | 1.31 | 1.14 | 1.21 | 1.24 | Upgrade
|
| Return on Equity (ROE) | 13.10% | 13.10% | 18.24% | 26.26% | 40.30% | 22.82% | Upgrade
|
| Return on Assets (ROA) | 2.21% | 2.21% | 3.90% | 6.79% | 6.88% | 4.16% | Upgrade
|
| Return on Capital (ROIC) | 2.77% | 2.77% | 4.93% | 8.86% | 9.14% | 5.28% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.70% | 4.70% | 7.90% | 14.50% | 16.20% | 10.10% | Upgrade
|
| Earnings Yield | 8.43% | 8.27% | 8.75% | 5.29% | 10.09% | 12.58% | Upgrade
|
| FCF Yield | -6.17% | -6.05% | -10.25% | -0.73% | 6.25% | 12.64% | Upgrade
|
| Dividend Yield | 3.63% | 3.51% | 1.95% | - | - | - | Upgrade
|
| Payout Ratio | 42.64% | 42.64% | 37.48% | 41.01% | 11.60% | 5.65% | Upgrade
|
| Buyback Yield / Dilution | -0.00% | -0.00% | - | 0.00% | - | - | Upgrade
|
| Total Shareholder Return | 3.63% | 3.51% | 1.95% | 0.00% | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.